Materials Healthcare Sector

Microbot Medical

Market Cap: US$93.2m

A clinical-stage medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space in Israel and the United States.

RetinalGenix Technologies

Market Cap: US$93.0m

RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders.

Genelux

Market Cap: US$92.9m

A clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.

Monogram Technologies

Market Cap: US$92.5m

Engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States.

HilleVax

Market Cap: US$92.3m

A clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States.

Corbus Pharmaceuticals Holdings

Market Cap: US$92.3m

A biopharmaceutical company, develops products to defeat serious illness.

Milestone Pharmaceuticals

Market Cap: US$92.1m

A biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.

Invivyd

Market Cap: US$91.2m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.

23andMe Holding

Market Cap: US$90.7m

Operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally.

Cabaletta Bio

Market Cap: US$90.3m

A clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases.

Coherus BioSciences

Market Cap: US$89.9m

A biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States.

Cardiol Therapeutics

Market Cap: CA$123.1m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Zentalis Pharmaceuticals

Market Cap: US$89.2m

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers.

Trajan Group Holdings

Market Cap: AU$137.9m

Develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India.

Entera Bio

Market Cap: US$89.1m

A clinical stage company, focuses on developing oral peptide or protein replacement therapies for unmet medical needs.

FONAR

Market Cap: US$88.4m

Engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States.

Immunic

Market Cap: US$88.2m

A biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.

Whitehawk Therapeutics

Market Cap: US$88.0m

An oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments.

Oramed Pharmaceuticals

Market Cap: US$87.8m

Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.

Satellos Bioscience

Market Cap: CA$119.4m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

CareCloud

Market Cap: US$86.8m

A healthcare information technology (IT) company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States.

Pheton Holdings

Market Cap: US$86.6m

A healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.

XBiotech

Market Cap: US$86.6m

A biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases.

Auxly Cannabis Group

Market Cap: CA$118.6m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

Cyclopharm

Market Cap: AU$133.4m

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally.

Fractyl Health

Market Cap: US$86.0m

A metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.

I-Mab

Market Cap: US$85.7m

A biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.

Genetic Signatures

Market Cap: AU$130.6m

Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.

Odysight.ai

Market Cap: US$84.0m

Develops, produces, and markets visualization AI solutions in Israel, the United States, and internationally.

Anixa Biosciences

Market Cap: US$83.7m

A biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology.

Owlet

Market Cap: US$83.4m

Provides digital parenting solutions in the United States, the United Kingdom, and internationally.

Medicus Pharma

Market Cap: US$83.0m

A biotech/life sciences company, focused on accelerating the clinical development programs of novel and disruptive therapeutic assets.

Planet 13 Holdings

Market Cap: CA$113.9m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Grown Rogue International

Market Cap: CA$113.6m

A craft cannabis company, focuses on premium flower and flower-derived products.

Pliant Therapeutics

Market Cap: US$82.3m

A biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases.

Protect Pharmaceutical

Market Cap: US$82.2m

Primarily focuses on crop farming and agricultural businesses.